ActiveMax® cytokines are a series of highly active recombinant cytokines developed by ACROBiosystems based on the HEK293 cells expression technology platform for immune cells, stem cells, and other cell cultures. ActiveMax® cytokines include Activin A, CCL19, Erythropoietin, Flt-3 Ligand, G-CSF, GM-CSF, IFN-gamma, IL-4, IL-6, IL-7, LIF, Oncostatin M, SCF, TGF-beta 1, TNF-alpha, VEGF110, VEGF120, VEGF121, VEGF164, VEGF165.
Key Features
- Tag free
- Carrier free
- High purity≥95%
- High bioactivity verified by cell-based assay
- Xenologous animal components free
- Native conformation and modification
- Low endotoxin≤1.0 EU/μg
- High batch-to-batch consistency
Image credit: ACROBiosystems
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Their mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. They supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, ACROBiosystems delivers solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. ACROBiosystems empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.